Literature DB >> 10620318

Structural and functional characterization of myotoxin I, a Lys49 phospholipase A(2) homologue from Bothrops moojeni (Caissaca) snake venom.

A M Soares1, S H Andrião-Escarso, Y Angulo, B Lomonte, J M Gutiérrez, S Marangoni, M H Toyama, R K Arni, J R Giglio.   

Abstract

Myotoxin-I (MjTX-I) was purified to homogeneity from the venom of Bothrops moojeni by ion-exchange chromatography on CM-Sepharose. Its molecular weight, estimated by SDS-PAGE, was 13,400 (reduced) or 26, 000 (unreduced). The extinction coefficient (E(1.0 mg/ml)(1.0 cm)) of MjTX-I was 1.145 at lambda = 278 nm, pH 7.0, and its isoelectric point was 8.2 at ionic strength mu = 0.1. When lyophilized and stored at 4 degrees C, dimeric, trimeric, and pentameric forms of the protein were identified by SDS-PAGE. This "heterogeneous" sample could be separated into three fractions by gel filtration on Sephadex G-50. The fractions were analyzed by isoelectric focusing, immunoelectrophoresis, and amino acid composition, which indicated that heterogeneity was the result of different levels of self-association. Protein sequencing indicated that MjTX-I is a Lys49 myotoxin and consists of 121 amino acids (M(r) = 13,669), containing a high proportion of basic and hydrophobic residues. It shares a high degree of sequence identity with other Lys49 PLA(2)-like myotoxins, but shows a significantly lower identity with catalytically active Asp49 PLA(2)s. The three-dimensional structure of MjTX-I was modeled based on the crystal structures of three highly homologous Lys49 PLA(2)-like myotoxins. This model showed that the amino acid substitutions are conservative, and mainly limited to three structural regions: the N-terminal helix, the beta-wing region, and the C-terminal extended random coil. MjTX-I displays local myotoxic and edema-inducing activities in mice, and is lethal by intraperitoneal injection, with an LD(50) value of 8.5 +/- 0.8 mg/kg. In addition, it is cytotoxic to myoblasts/myotubes in culture, and disrupts negatively charged liposomes. In comparison with the freshly prepared dimeric sample, the more aggregated forms showed significantly reduced myotoxic activity. However, the edema-inducing activity of MjTX-I was independent of molecular association. Phospholipase A(2) activity on egg yolk, as well as anticoagulant activity, were undetectable both in the native and in the more associated forms. His, Tyr, and Trp residues of the toxin were chemically modified by specific reagents. Although the myotoxic and lethal activities of the modified toxins were reduced by these treatments, neither its edema-inducing or liposome-disrupting activities were significantly altered. Rabbit antibodies to native MjTX-I cross-reacted with the chemically modified forms, and both the native and modified MjTX-I preparations were recognized by antibodies against the C-terminal region 115-129 of myotoxin II from B. asper, a highly Lys49 PLA(2)-homologue with high sequencial similarity. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620318     DOI: 10.1006/abbi.1999.1492

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  15 in total

1.  Biological and structural characterization of a new PLA2 from the Crotalus durissus collilineatus venom.

Authors:  M H Toyama; D O Toyama; Paulo P Joazeiro; E M Carneiro; L O S Beriam; L S Marangoni; A C Boschero
Journal:  Protein J       Date:  2005-02       Impact factor: 2.371

2.  Lys49 myotoxin from the Brazilian lancehead pit viper elicits pain through regulated ATP release.

Authors:  Chuchu Zhang; Katalin F Medzihradszky; Elda E Sánchez; Allan I Basbaum; David Julius
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-06       Impact factor: 11.205

3.  Crystallization and preliminary X-ray diffraction analysis of myotoxin I, a Lys49-phospholipase A2 from Bothrops moojeni.

Authors:  D P Marchi-Salvador; L B Silveira; A M Soares; M R M Fontes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-09-13

4.  Structural characterization of myotoxic ecarpholin S from Echis carinatus venom.

Authors:  Xingding Zhou; Tien-Chye Tan; S Valiyaveettil; Mei Lin Go; R Manjunatha Kini; Adrian Velazquez-Campoy; J Sivaraman
Journal:  Biophys J       Date:  2008-06-27       Impact factor: 4.033

5.  Effects of low molecular weight sulfated galactan fragments from Botryocladia occidentalis on the pharmacological and enzymatic activity of sPLA2 from Crotalus durissus cascavella.

Authors:  M H Toyama; D O Toyama; V M Torres; G C Pontes; W R L Farias; F R Melo; S C B Oliveira; F H R Fagundes; E B S Diz Filho; B S Cavada
Journal:  Protein J       Date:  2010-11       Impact factor: 2.371

6.  Induction of mast cell accumulation, histamine release and skin edema by N49 phospholipase A2.

Authors:  Ji-Fu Wei; Xiao-Long Wei; Ya-Zhen Mo; Shao-Heng He
Journal:  BMC Immunol       Date:  2009-04-28       Impact factor: 3.615

7.  Bmoo FIBMP-I: A New Fibrinogenolytic Metalloproteinase from Bothrops moojeni Snake Venom.

Authors:  F S Torres; B Rates; M T R Gomes; C E Salas; A M C Pimenta; F Oliveira; M M Santoro; M E de Lima
Journal:  ISRN Toxicol       Date:  2012-11-04

8.  Structural and phylogenetic studies with MjTX-I reveal a multi-oligomeric toxin--a novel feature in Lys49-PLA2s protein class.

Authors:  Guilherme H M Salvador; Carlos A H Fernandes; Angelo J Magro; Daniela P Marchi-Salvador; Walter L G Cavalcante; Roberto M Fernandez; Márcia Gallacci; Andreimar M Soares; Cristiano L P Oliveira; Marcos R M Fontes
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

9.  Induction of mast-cell accumulation by promutoxin, an Arg-49 phospholipase A2.

Authors:  Ji-Fu Wei; Xiao-Long Wei; Ya-Zhen Mo; Haiwei Yang; Shaoheng He
Journal:  Biomed Res Int       Date:  2012-12-20       Impact factor: 3.411

10.  Purification and preliminary crystallographic analysis of a new Lys49-PLA2 from B. Jararacussu.

Authors:  Marcelo L Dos Santos; Fábio H R Fagundes; Bruno R F Teixeira; Marcos H Toyama; Ricardo Aparicio
Journal:  Int J Mol Sci       Date:  2008-05-08       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.